In patients with luminal A BC, a high mRNA expression of CLDN1, 2, 5, 6, 8, 9, 10, 11, and 14 to 20 correlated with better RFS, whereas only a high CLDN3 expression was associated with poor RFS. Here, CLDN3 is linked to breast cancer.